Streetbeat News

Stock Prices

GILD

Gilead shares are trading lower after the company's Phase 3 TROPiCS-04 study missed its primary endpoint of overall survival.

Portfolio Pulse from Benzinga Newsdesk

May 30, 2024 | 8:46 pm

GILD

Gilead Sciences announced that its Phase 3 TROPiCS-04 study for Trodelvy in metastatic urothelial cancer did not meet its primary endpoint of overall survival.

Portfolio Pulse from Benzinga Newsdesk

May 30, 2024 | 8:45 pm

DX

Dynex Capital has appointed Marie Chandoha, former President and CEO of Charles Schwab Investment Management, to its Board of Directors.

Portfolio Pulse from Benzinga Newsdesk

May 30, 2024 | 8:45 pm

ONCT

Oncternal Therapeutics, Inc. (NASDAQ:ONCT) has completed enrollment and initiated dosing for the fifth dose cohort in its Phase 1/2 study of ONCT-534 for treating metastatic castration-resistant prostate cancer. The Safety Review Committee approved the 600 mg dose after reviewing data from the 300 mg dose. Initial safety and efficacy data are expected in Q3 2024.

Portfolio Pulse from Benzinga Newsdesk

May 30, 2024 | 8:45 pm

NXTC

NextCure, Inc. (NASDAQ:NXTC) will present Phase 1b data on the combination of NC410 and pembrolizumab at the ASCO 2024 Annual Meeting. The trial showed promising results in MSS/MSI-L CRC and ovarian cancer patients, with notable disease control rates.

Portfolio Pulse from Benzinga Newsdesk

May 30, 2024 | 8:43 pm

VEEV

Veeva Systems shares are trading lower after the company issued weak revenue guidance.

Portfolio Pulse from Benzinga Newsdesk

May 30, 2024 | 8:43 pm

AFBI

Trading halt status updated at 4:40:00 PM ET for AFBI. Quotation resumption times and news updates are provided.

Portfolio Pulse from Benzinga Newsdesk

May 30, 2024 | 8:40 pm

DJT

RUM

SPY

A jury has reached a verdict in Donald Trump's hush money criminal trial, which could have implications for companies and ETFs associated with Trump.

Portfolio Pulse from Benzinga Newsdesk

May 30, 2024 | 8:38 pm

ULTA

Ulta Beauty (NASDAQ: ULTA) reported better-than-expected Q1 earnings and sales, but lowered its FY24 guidance. The company saw a 1.6% increase in comparable sales and opened 12 new stores. Despite the positive Q1 results, Ulta adjusted its full-year sales and EPS guidance downward, anticipating continued challenges.

Portfolio Pulse from Erica Kollmann

May 30, 2024 | 8:35 pm

AMLI

American Lithium reported a fiscal year 2024 EPS of C$(0.19), which is a decline compared to the previous year's EPS of C$(0.17).

Portfolio Pulse from Benzinga Newsdesk

May 30, 2024 | 8:35 pm